Table 2.
Classification (n) | Symptom score (Median) | Range | QoL score (Median) | Range |
---|---|---|---|---|
New (n = 250) | 18 | 12–21 | 19 | 16–24 |
Worsening (n = 100) | ||||
Before COVID-19 | 8 | 4–10 | 9 | 8–10 |
After COVID-19* | 19* | 17–21* | 20* | 19–20* |
Female (n = 140) | 18 | 15–21 | 19 | 16–21 |
Male (n = 210) | 18 | 12–20 | 19 | 16–20 |
*Only “After COVID-19” symptom scores for patients with preexisting OAB are included in the male/female analysis